Cell sources for cardiovascular tissue regeneration and engineering

Thoracic and Cardiovascular Surgeon

Volumn 57, Issue 2, 2009, Pages 63-73

  Ugurlucan, M ^a   Yerebakan, C ^a   Furlani, D ^a   Ma, N ^a   Steinhoff, G ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Myocardium; Stem cell; Tissue engineering

Indexed keywords

ADIPOSE TISSUE CELL; CARDIOVASCULAR SURGERY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE; HEART MUSCLE CELL; HEART VALVE; HEART VENTRICLE REMODELING; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; SPERMATOGONIUM; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; UMBILICAL CORD; VASCULAR SMOOTH MUSCLE; ANIMAL; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; REGENERATIVE MEDICINE; STEM CELL; TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MYOCARDIUM; MYOCYTES, CARDIAC; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 65449163880     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-2008-1039235     Document Type: Review

References (104)

1. Wu KH, Liu YL, Zhou B, Han ZC. Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells. Eur J Cardiothorac Surg 2006;30:770-781
2. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005;115:572-583
3. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg RV, Kögler G, Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-1918
4. Dib N, Michler RE, Pagani FD, Wright S, Kereiakes DJ, Lengerich R, Binkley P, Buchele D, Anand I, Swingen C, Di Carli MF, Thomas JD, Jaber WA, Opie SR, Campbell A, McCarthy P, Yeager M, Dilsizian V, Griffith BP, Korn R, Kreuger SK, Ghazoul M, MacLellan WR, Fonarow G, Eisen HJ, Dinsmore J, Diethrich E. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005;20(112):1748-1755
5. Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G, Hoefer IE, Mueller-Hoecker J, Franz WM. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J 2006;20:956-958
6. Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, Fischer-Rasokat U, Heeschen C, Spyridopoulos I, Dimmeler S, Zeiher AM. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 2007;19(49):2341-2349
7. Tse HF, Thambar S, Kwong YL, Rowlings P, Bellamy G, McCrohon J, Bastian B, Chan JK, Lo G, Ho CL, Lau CP. Safety of catheter-based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis. Am J Cardiol 2006;1(98):60-62
8. Galiñanes M, Loubani M, Davies J, Chin D, Pasi J, Bell PR. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant 2004;13:7-13
9. Theiss HD, David R, Engelmann MG, Barth A, Schotten K, Naebauer M, Reichart B, Steinbeck G, Franz WM. Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur Heart J 2007;28:1258-1264
10. Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B, David A, Liebold A, Nienaber C, Zurakowski D, Freund M, Steinhoff G. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007;133:717-725
11. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;21(355):1210-1221
12. Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel Jr HC, Kormos R, Benetti F. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005;130:1631-1638
13. Yerebakan C, Kaminski A, Westphal B, Liebold A, Steinhoff G. Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting. Minim Invasive Ther Allied Technol 2008;17:143-148
14. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004;95:9-20
15. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schümichen C, Nienaber CA, Freund M, Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361(4):45-46
16. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-148
17. Engelmann MG, Theiss HD, Hennig-Theiss C, Huber A, Wintersperger BJ, Werle-Ruedinger AE, Schoenberg SO, Steinbeck G, Franz WM. Autologous bone marrow stem cell mobilization induced by granulocyte colonystimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 2006;48:1712-1721
18. Gordon EM, Anderson WF. Gene therapy using retroviral vectors. Curr Opin Biotechnol 1994;5:611-616
19. Ping P, Yang Q, Hammond HK. Altered beta-adrenergic receptor signaling in heart failure, in vivo gene transfer via adeno and adeno-associated virus. Microcirculation 1996;3:225-228
20. Malosky S, Kolansky DM. Gene therapy for ischemic heart disease. Curr Opin Cardiol 1996;11:361-368
21. Zammaretti P, Jaconi M. Cardiac tissue engineering: regeneration of the wounded heart. Curr Opin Biotechnol 2004;15:430-434
22. Stamm C, Steinhoff G. When less is more: go slowly when repopulating a decellularized valve in vivo! J Thorac Cardiovasc Surg 2006;132:735-737
23. Stamm C, Khosravi A, Grabow N, Schmohl K, Treckmann N, Drechsel A, Nan M, Schmitz KP, Haubold A, Steinhoff G. Biomatrix/polymer composite material for heart valve tissue engineering. Ann Thorac Surg 2004;78:2084-2092
24. Grabow N, Schmohl K, Khosravi A, Philipp M, Scharfschwerdt M, Graf B, Stamm C, Haubold A, Schmitz KP, Steinhoff G. Mechanical and structural properties of a novel hybrid heart valve scaffold for tissue engineering. Artif Organs 2004;28:971-979
25. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 2000;102(19 Suppl. 3) : III50-III55
26. Bader A, Steinhoff G, Strobl K, Schilling T, Brandes G, Mertsching H, Tsikas D, Froelich J, Haverich A. Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation 2000;70:7-14
27. Simon A, Wilhelmi M, Steinhoff G, Harringer W, Brücke P, Haverich A. Cardiac valve endothelial cells: relevance in the long-term function of biologic valve prostheses. J Thorac Cardiovasc Surg 1998;116:609-616
28. Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A. Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 1998;14:279-284
29. Yang C, Sodian R, Fu P, Lüders C, Lemke T, Du J, Hübler M, Weng Y, Meyer R, Hetzer R. In vitro fabrication of a tissue engineered human cardiovascular patch for future use in cardiovascular surgery. Ann Thorac Surg 2006;81:57-63
30. Zimmermann WH, Didié M, Döker S, Melnychenko I, Naito H, Rogge C, Tiburcy M, Eschenhagen T.Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res 2006;71:419-429
31. Zimmermann WH, Melnychenko I, Wasmeier G, Didié M, Naito H, Nixdorff U, Hess A, Budinsky L, Brune K, Michaelis B, Dhein S, Schwoerer A, Ehmke H, Eschenhagen T. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006;12:452-458
32. Eschenhagen T, Zimmermann WH. Engineering myocardial tissue. Circ Res 2005;97:1220-1231
33. Eschenhagen T, Didié M, Münzel F, Schubert P, Schneiderbanger K, Zimmermann WH. 3D engineered heart tissue for replacement therapy. Basic Res Cardiol 2002;97(Suppl. 1) : I146-I152
34. Steinhoff G. The regenerating heart - hope for children with congenital heart defects. Kinderkrankenschwester 2006;25:47-50
35. Garry DJ, Olson EN. A common progenitor at the heart of development. Cell 2006;127:1101-1104
36. Kattman SJ, Huber TL, Keller GM. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006;11:723-732
37. Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y, Qyang Y, Bu L, Sasaki M, Martin-Puig S, Sun Y, Evans SM, Laugwitz KL, Chien KR. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006;127:1151-1165
38. Srivastava D. Genetic regulation of cardiogenesis and congenital heart disease. Annu Rev Pathol 2006;1:199-213
39. Kelly RG, Brown NA, Buckingham ME. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell 2001;1:435-440
40. Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J, Evans S. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003;5:877-889
41. Abu-Issa R, Waldo K, Kirby ML. Heart fields: one, two or more? Dev Biol 2004;272:281-285
42. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005;6:826-835
43. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu MM, Reth M, Platoshyn O, Yuan JX, Evans S, Chien KR. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005;433:647-653
44. Olson EN. Gene regulatory networks in the evolution and development of the heart. Science 2006;313:1922-1927
45. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 2005;85:1373-1416
46. Ma N, Stamm C, Kaminski A, Li W, Kleine HD, Müller-Hilke B, Zhang L, Ladilov Y, Egger D, Steinhoff G. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/SCID-mice. Cardiovasc Res 2005;66:45-54
47. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, Nurzynska D, Kasahara H, Zias E, Bonafé M, Nadal-Ginard B, Torella D, Nascimbene A, Quaini F, Urbanek K, Leri A, Anversa P. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005;96:127-137
48. Pouly J, Bruneval P, Mandet C, Proksch S, Peyrard S, Amrein C, Bousseaux V, Guillemain R, Deloche A, Fabiani JN, Menasché P. Cardiac stem cells in the real world. J Thorac Cardiovasc Surg 2008;135:673-678
49. Balsam LB, Robbins RC.Haematopoietic stem cells and repair of the ischaemic heart. Clin Sci (Lond) 2005;109:483-492
50. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-668
51. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-673
52. Werner N, Wassmann S, Ahlers P, Schiegl T, Kosiol S, Link A, Walenta K, Nickenig G. Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007;102:565-571
53. Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler Thromb Vasc Biol 2006;26:257-266
54. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004;8:498-508
55. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600
56. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007
57. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003;108:2511-2516
58. Rangappa S, Entwistle JW, Wechsler AS, Kresh JY. Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardiovasc Surg 2003;126:124-132
59. Oswald J, Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhäuser M, Werner C. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004;22:377-384
60. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM.Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49
61. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC.Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004;117(Pt 14) : 2971-2981
62. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-776
63. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW, Lecapitaine N, Cascapera S, Beltrami AP, D'Alessandro DA, Zias E, Quaini F, Urbanek K, Michler RE, Bolli R, Kajstura J, Leri A, Anversa P. Human cardiac stem cells. Proc Natl Acad Sci USA 2007;104:14068-14073
64. Leor J, Cohen S. Myocardial tissue engineering: creating a muscle patch for a wounded heart. Ann NY Acad Sci 2004;1015:312-319
65. Menasché P. Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis 2007;50:7-17
66. Pouly J, Hagège AA, Vilquin JT, Bissery A, Rouche A, Bruneval P, Duboc D, Desnos M, Fiszman M, Fromes Y, Menasché P. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Circulation 2004;110:1626-1631
67. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breitbach M, Doran R, Becher UM, Hwang SM, Bostani T, von Maltzahn J, Hofmann A, Reining S, Eiberger B, Gabris B, Pfeifer A, Welz A, Willecke K, Salama G, Schrickel JW, Kotlikoff MI, Fleischmann BK. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007;450:819-824
68. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-933
69. Rangappa S, Fen C, Lee EH, Bongso A, Sim EK. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 2003;75:775-779
70. Planat-Benard V, Silvestre JS, Cousin B, André M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Pénicaud L, Casteilla L. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004;109:656-663
71. Kadner A, Zund G, Maurus C, Breymann C, Yakarisik S, Kadner G, Turina M, Hoerstrup SP. Human umbilical cord cells for cardiovascular tissue engineering: a comparative study. Eur J Cardiothorac Surg 2004;25:635-641
72. Furfaro EM, Gaballa MA. Do adult stem cells ameliorate the damaged myocardium? Human cord blood as a potential source of stem cells. Curr Vasc Pharmacol 2007;5:27-44
73. Henning RJ, Abu-Ali H, Balis JU, Morgan MB, Willing AE, Sanberg PR. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant 2004;13:729-739
74. Ma N, Ladilov Y, Moebius JM, Ong L, Piechaczek C, Dávid A, Kaminski A, Choi YH, Li W, Egger D, Stamm C, Steinhoff G. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: bone marrow vs. cord blood-derived cells. Cardiovasc Res 2006;71:158-169
75. Moelker AD, Baks T, Wever KM, Spitskovsky D, Wielopolski PA, van Beusekom HM, van Geuns RJ, Wnendt S, Duncker DJ, van der Giessen WJ.Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine. J Mol Cell Cardiol 2007;42:735-745
76. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-414
77. Erdö F, Bührle C, Blunk J, Hoehn M, Xia Y, Fleischmann B, Föcking M, Küstermann E, Kolossov E, Hescheler J, Hossmann KA, Trapp T. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 2003;23:780-785
78. Kofidis T, de Bruin JL, Hoyt G, Ho Y, Tanaka M, Yamane T, Lebl DR, Swijnenburg RJ, Chang CP, Quertermous T, Robbins RC.Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J Heart Lung Transplant 2005;24:737-744
79. Guan K, Nayernia K, Maier LS, Wagner S, Dressel R, Lee JH, Nolte J, Wolf F, Li M, Engel W, Hasenfuss G. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 2006;440:1199-1203
80. Seandel M, James D, Shmelkov SV, Falciatori I, Kim J, Chavala S, Scherr DS, Zhang F, Torres R, Gale NW, Yancopoulos GD, Murphy A, Valenzuela DM, Hobbs RM, Pandolfi PP, Rafii S. Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. Nature 2007;449:346-350
81. Guan K, Wagner S, Unsöld B, Maier LS, Kaiser D, Hemmerlein B, Nayernia K, Engel W, Hasenfuss G. Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells. Circ Res 2007;100:1615-1625
82. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis 2004;13:841-847
83. Merryman WD, Liao J, Parekh A, Candiello JE, Lin H, Sacks MS. Differences in tissue-remodeling potential of aortic and pulmonary heart valve interstitial cells. Tissue Eng 2007;13:2281-2289
84. Rabkin-Aikawa E, Aikawa M, Farber M, Kratz JR, Garcia-Cardena G, Kouchoukos NT, Mitchell MB, Jonas RA, Schoen FJ. Clinical pulmonary autograft valves: pathologic evidence of adaptive remodeling in the aortic site. J Thorac Cardiovasc Surg 2004;128:552-561
85. Matsubayashi K, Fedak PW, Mickle DA, Weisel RD, Ozawa T, Li RK. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 2003;108(Suppl. 1) : II219-II225
86. Ruhparwar A, Kofidis T, Ruebesamen N, Karck M, Haverich A, Martin U. Intra-vital fluorescence microscopy for intra-myocardial graft detection following cell transplantation. Int J Cardiovasc Imaging 2005;21:569-574
87. Rubio D, Garcia-Castro J, Martín MC, de la Fuente R, Cigudosa JC, Lloyd AC, Bernad A. Spontaneous human adult stem cell transformation. Cancer Res 2005;65:3035-3039
88. Kofidis T, Akhyari P, Boublik J, Theodorou P, Martin U, Ruhparwar A, Fischer S, Eschenhagen T, Kubis HP, Kraft T, Leyh R, Haverich A. In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg 2002;124:63-69
89. Zimmermann WH, Melnychenko I, Eschenhagen T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 2004;25:1639-1647
90. Forbess JM, Shah AS, St Louis JD, Jaggers JJ, Ungerleider RM. Cryopreserved homografts in the pulmonary position: determinants of durability. Ann Thorac Surg 2001;71:54-59
91. Stark J, Bull C, Stajevic M, Jothi M, Elliott M, de Leval M. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg 1998;115:506-514
92. Marshall SE, Tweedt SM, Greene CH, Ballestas LY, Bunning KR, Costa LE, Harrison TD, Higgins CM, Hoertz MJ, Hollobaugh DA, Jaffe JS, Koenig GJ, Lewbart MB, Liccini MS, Lopez CS, Lynch GS, Marshall JO, Mazzoni JA, Moeller JP, Raab DC, Reap JC, Selgrath CE, Sweitzer LM, Valentino DJ, Vota SA.An alternative to synthetic aortic grafts using jejunum. J Invest Surg 2000;13:333-341
93. Allman AJ, McPherson TB, Badylak SF, Merrill LC, Kallakury B, Sheehan C, Raeder RH, Metzger DW.Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation 2001;71:1631-1640
94. Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe K, Kikuchi A, Umezu M, Okano T. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002;90: e40
95. Fuchs JR, Nasseri BA, Vacanti JP, Fauza DO. Postnatal myocardial augmentation with skeletal myoblast-based fetal tissue engineering. Surgery 2006;140:100-107
96. Siepe M, Giraud MN, Pavlovic M, Receputo C, Beyersdorf F, Menasché P, Carrel T, Tevaearai HT. Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure. J Thorac Cardiovasc Surg 2006;132:124-131
97. Kubo Y, Sekiya S, Ohigashi M, Takenaka C, Tamura K, Nada S, Nishi T, Yamamoto A, Yamaguchi A.ABCA5 resides in lysosomes, and ABCA5 knockout mice develop lysosomal disease-like symptoms. Mol Cell Biol 2005;25:4138-4149
98. Memon IA, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Taketani S, Sakakida SK, Kondoh H, Aleshin AN, Shimizu T, Okano T, Matsuda H. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg 2005;130:1333-1341
99. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, Ishino K, Ishida H, Shimizu T, Kangawa K, Sano S, Okano T, Kitamura S, Mori H. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-465
100. Naito H, Melnychenko I, Didié M, Schneiderbanger K, Schubert P, Rosenkranz S, Eschenhagen T, Zimmermann WH.Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006;114(Suppl. 1) : I72-I78
101. Krupnick AS, Kreisel D, Riha M, Balsara KR, Rosengard BR.Myocardial tissue engineering and regeneration as a therapeutic alternative to transplantation. Curr Top Microbiol Immunol 2004;280:139-164
102. Zeiher AM. Successful double-blind study of post-infarction patients. Repairing the heart with bone marrow (interview by Dr. med. Jochen Aumiller). MMW Fortschr Med 2005;147(48):13
103. Pompilio G, Steinhoff G, Liebold A, Pesce M, Alamanni F, Capogrossi MC, Biglioli P.Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results. Thorac Cardiovasc Surg 2008;56(2):71-76
104. Klein HM, Ghodsizad A, Marktanner R, Poll L, Voelkel T, Mohammad Hasani MR, Piechaczek C, Feifel N, Stockschlaeder M, Burchardt ER, Kar BJ, Gregoric I, Gams E. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg Forum 2007;10(1) : E66-69